CCSVI Alliance is pleased to announce that Dr. Gary Siskin and Community Care Physicians have received official IDE (investigational device exemption) approval from the FDA to explore CCSVI.

Dr. Siskin's group can now begin actively recruiting for their CCSVI trial.  

link to Community Care Physicians CCSVI Clinical Trial

Other researchers ahould be receiving approval in the near future, and CCSVI Alliance is confident that this measure will facilitate robust research into the connection of CCSVI and Multiple Sclerosis.

We are grateful to Dr. Siskin for his continuing exploration of CCSVI in MS, and proud that he trusts the Alliance to make this announcement and share this with the MS community.

Now into our third year of operation, CCSVI Alliance continues to promote education and research about CCSVI and its relationship to Multiple Sclerosis (MS) by providing objective information to the MS community, supporting medical investigations of CCSVI, and fostering collaboration among patients, advocates, and professionals.

We can't do this without your help.  Please consider making a tax deductable donation today.

How to donate

Thank you for your support!